ARA-290, also known as Cibinetide, is a synthetic peptide derived from erythropoietin (EPO). It is being investigated for its potential role in tissue protection, inflammatory signalling and nerve repair, particularly in preclinical research and early-stage clinical studies involving small-fibre neuropathy.
Unlike conventional EPO, ARA-290 is designed to investigate tissue-protective pathways without stimulating red blood cell production.
-
Laboratory-grade quality; research use only (RUO).
-
99%+ purity targets; batch-tested and independently verified.
-
Australian express shipping (AusPost) with tracking.
-
Simple research preparation calculator for laboratory preparation.
-
Secure checkout and fast fulfilment.
-
Ethical sourcing and responsive, knowledgeable customer service.
Important: ARA-290 remains an investigational compound. Its safety and effectiveness for treating medical conditions have not been established.
All BT7 products are for laboratory research only and not for human or veterinary use.
Purchasers must be at least 21 years of age and agree to our Terms & Conditions at checkout.
Reviews
There are no reviews yet.